1,387
Views
2
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities

ORCID Icon & ORCID Icon
Article: 2275962 | Received 28 Jul 2023, Accepted 24 Oct 2023, Published online: 09 Nov 2023

References

  • Leonard MJ, Philippe FL. Conspiracy theories: a Public health concern and how to address it. Front Psychol. 2021;12:682931. doi:10.3389/fpsyg.2021.682931.
  • Oliver JE, Wood T. Medical conspiracy theories and health behaviors in the United States. JAMA Intern Med. 2014;174:817–15. doi:10.1001/jamainternmed.2014.190.
  • Salazar-Fernández C, Baeza-Rivera MJ, Manríquez-Robles D, Salinas-Oñate N, Sallam M. From conspiracy to hesitancy: the longitudinal impact of COVID-19 vaccine conspiracy theories on perceived vaccine effectiveness. Vaccines. 2023;11(7):1150. doi:10.3390/vaccines11071150.
  • van Prooijen JW, Etienne TW, Kutiyski Y, Krouwel APM. Conspiracy beliefs prospectively predict health behavior and well-being during a pandemic. Psychol Med. 2023;53:2514–21. doi:10.1017/s0033291721004438.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9:42. doi:10.3390/vaccines9010042.
  • Islam MS, Sarkar T, Khan SH, Mostofa Kamal AH, Hasan SMM, Kabir A, Yeasmin D, Islam MA, Amin Chowdhury KI, Anwar KS, et al. COVID-19–related infodemic and its impact on public health: A global social media analysis. Am J Trop Med Hyg. 2020;103:1621–9. doi:10.4269/ajtmh.20-0812.
  • Bavel JJV, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, Crockett MJ, Crum AJ, Douglas KM, Druckman JN, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4:460–71. doi:10.1038/s41562-020-0884-z.
  • Earnshaw VA, Eaton LA, Kalichman SC, Brousseau NM, Hill EC, Fox AB. COVID-19 conspiracy beliefs, health behaviors, and policy support. Transl Behav Med. 2020;10:850–6. doi:10.1093/tbm/ibaa090.
  • Juanchich M, Sirota M, Jolles D, Whiley LA. Are COVID-19 conspiracies a threat to public health? Psychological characteristics and health protective behaviours of believers. Eur J Soc Psychol. 2021;51:969–89. doi:10.1002/ejsp.2796.
  • Pertwee E, Simas C, Larson HJ. An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy. Nat Med. 2022;28:456–9. doi:10.1038/s41591-022-01728-z.
  • Bierwiaczonek K, Kunst JR, Pich O. Belief in COVID-19 conspiracy theories reduces social distancing over time. Appl Psychol Health Well Being. 2020;12:1270–85. doi:10.1111/aphw.12223.
  • Mahmood S, Hussain T, Mahmood F, Ahmad M, Majeed A, Beg BM, Areej S. Attitude, perception, and Knowledge of COVID-19 among general Public in Pakistan. Front Public Health. 2020;8:602434. doi:10.3389/fpubh.2020.602434.
  • van Mulukom V, Pummerer LJ, Alper S, Bai H, Čavojová V, Farias J, van Mulukom V, Kay CS, Lazarevic LB, Lobato EJC, et al. Antecedents and consequences of COVID-19 conspiracy beliefs: a systematic review. Social Sci Med. 2022;301:114912. doi:10.1016/j.socscimed.2022.114912.
  • Sallam M, Al-Sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc. 2022;15:21–45. doi:10.2147/jmdh.S347669.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9:160. doi:10.3390/vaccines9020160.
  • Ecker UKH, Lewandowsky S, Cook J, Schmid P, Fazio LK, Brashier N, Kendeou P, Vraga EK, Amazeen MA. The psychological drivers of misinformation belief and its resistance to correction. Nat Rev Psychol. 2022;1:13–29. doi:10.1038/s44159-021-00006-y.
  • Prooijen JV. Psychological benefits of believing conspiracy theories. Curr Opin Psychol. 2022;47:101352. doi:10.1016/j.copsyc.2022.101352.
  • Jolley D, Douglas KM. The effects of anti-vaccine conspiracy theories on vaccination intentions. PLoS One. 2014;9:e89177. doi:10.1371/journal.pone.0089177.
  • Douglas KM, Sutton RM, Cichocka A. The psychology of conspiracy theories. Curr Dir Psychol Sci. 2017;26:538–42. doi:10.1177/0963721417718261.
  • van Prooijen JW, Douglas KM. Belief in conspiracy theories: basic principles of an emerging research domain. Eur J Soc Psychol. 2018;48:897–908. doi:10.1002/ejsp.2530.
  • De Coninck D, Frissen T, Matthijs K, d’Haenens L, Lits G, Champagne-Poirier O, d’Haenens L, Carignan M-E, David MD, Pignard-Cheynel N, et al. Beliefs in conspiracy theories and misinformation about COVID-19: comparative perspectives on the role of anxiety, depression and exposure to and trust in information sources. Front Psychol. 2021;12:646394. doi:10.3389/fpsyg.2021.646394.
  • Pavela Banai I, Banai B, Mikloušić I. Beliefs in COVID-19 conspiracy theories, compliance with the preventive measures, and trust in government medical officials. Curr Psychol. 2022;41:7448–58. doi:10.1007/s12144-021-01898-y.
  • Bertin P, Nera K, Delouvée S. Conspiracy beliefs, rejection of vaccination, and support for hydroxychloroquine: a conceptual replication-extension in the COVID-19 pandemic context. Front Psychol. 2020;11:565128. doi:10.3389/fpsyg.2020.565128.
  • Larson HJ, Broniatowski DA. Volatility of vaccine confidence. Science. 2021;371:1289. doi:10.1126/science.abi6488.
  • Larson HJ, Gakidou E, Murray CJL. The vaccine-hesitant moment. N Engl J Med. 2022;387:58–65. doi:10.1056/NEJMra2106441.
  • Enea V, Eisenbeck N, Carreno DF, Douglas KM, Sutton RM, Agostini M, Bélanger JJ, Gützkow B, Kreienkamp J, Abakoumkin G, et al. Intentions to be vaccinated against COVID-19: the role of prosociality and conspiracy beliefs across 20 countries. Health Commun. 2023;38:1530–9. doi:10.1080/10410236.2021.2018179.
  • World Health Organization. Regional Office for Europe. Communicating with patients about COVID-19 vaccination: evidence-based guidance for effective conversations to promote COVID-19 vaccine uptake. [accessed 2023 Jul 1]. https://apps.who.int/iris/handle/10665/340751.
  • Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32:2150–9. doi:10.1016/j.vaccine.2014.01.081.
  • Dubé E, Gagnon D, Vivion M. Optimizing communication material to address vaccine hesitancy. Can Commun Dis Rep. 2020;46:48–52. doi:10.14745/ccdr.v46i23a05.
  • Lewandowsky S, Cook J, Schmid P, Holford DL, Finn A, Leask J, Thomson A, Lombardi D, Al-Rawi AK, Amazeen MA, et al. The COVID-19 vaccine communication handbook. A practical guide for improving vaccine communication and fighting misinformation. 2021.
  • Wise J. Covid-19: WHO declares end of global health emergency. BMJ. 2023;381:1041. doi:10.1136/bmj.p1041.
  • Mahase E. Covid-19: JCVI recommends autumn vaccine booster for the most vulnerable. BMJ. 2023;380:204. doi:10.1136/bmj.p204.
  • Mahase E. Covid-19: annual flu-like booster approach may not be appropriate, says expert on infectious disease. BMJ. 2023;380:196. doi:10.1136/bmj.p196.
  • Betsch C, Schmid P, Verger P, Lewandowsky S, Soveri A, Hertwig R, Fasce A, Holford D, De Raeve P, Gagneur A, et al. A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter. Nat Commun. 2022;13:7511. doi:10.1038/s41467-022-34995-y.
  • Silk BJ, Scobie HM, Duck WM, Palmer T, Ahmad FB, Binder AM, Cisewski JA, Kroop S, Soetebier K, Park M, et al. COVID-19 surveillance after expiration of the public health emergency declaration ― United States, May 11, 2023. Morb Mortal Wkly Rep. 2023;72:523–8. doi:10.15585/mmwr.mm7219e1.
  • Chi W-Y, Li Y-D, Huang H-C, Chan TEH, Chow S-Y, Su J-H, Ferrall L, Hung C-F, Wu T-C. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci. 2022;29:82. doi:10.1186/s12929-022-00853-8.
  • Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015;7. doi:10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.
  • MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4. doi:10.1016/j.vaccine.2015.04.036.
  • Almeshari M, Abanomy A, Alzamil Y, Alyahyawi A, Al-Thomali AW, Alshihri AA, Althomali OW. Public acceptance of COVID-19 vaccination among residents of Saudi Arabia: a cross-sectional online study. BMJ Open. 2022;12:e058180. doi:10.1136/bmjopen-2021-058180.
  • El Hassan ELW, Abu Alhommos AK, Aliadhy D, Alsalman S, Alnafaa O, Public Knowledge MA. Beliefs and attitudes toward the COVID-19 vaccine in Saudi Arabia: a cross-sectional study. Healthcare (Basel). 2022;10(5):853. doi:10.3390/healthcare10050853.
  • Al Naam YA, Elsafi SH, Alkharraz ZS, Almaqati TN, Alomar AM, Al Balawi IA, Jebakumar AZ, Ghazwani AA, Almusabi SS, Albusaili S, et al. Factors related to COVID-19 vaccine hesitancy in Saudi Arabia. Public Health Pract (Oxf). 2022;3:100258. doi:10.1016/j.puhip.2022.100258.
  • Alfageeh EI, Alshareef N, Angawi K, Alhazmi F, Chirwa GC. Acceptability of a COVID-19 Vaccine among the Saudi Population. Vaccines (Basel). 2021;9:226. doi:10.3390/vaccines9030226.
  • Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 vaccine acceptance among healthcare workers in Kuwait: a cross-sectional study using the 5C and vaccine conspiracy beliefs scales. Vaccines. 2021;9:701. doi:10.3390/vaccines9070701.
  • Freeman D, Waite F, Rosebrock L, Petit A, Causier C, East A, Jenner L, Teale A-L, Carr L, Mulhall S, et al. Coronavirus conspiracy beliefs, mistrust, and compliance with government guidelines in England. Psychol Med. 2022;52:251–63. doi:10.1017/s0033291720001890.
  • Sallam M, Eid H, Awamleh N, Al-Tammemi AB, Barakat M, Athamneh RY, Hallit S, Harapan H, Mahafzah A. Conspiratorial attitude of the general Public in Jordan towards emerging virus infections: a cross-sectional study amid the 2022 monkeypox outbreak. Trop Med Infect Dis. 2022;7:411. doi:10.3390/tropicalmed7120411.
  • Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, Parsons Leigh J, Hu J, El-Mohandes A. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13:3801. doi:10.1038/s41467-022-31441-x.
  • Chutiyami M, Salihu D, Bello UM, Winser SJ, Gambo AA, Sabo H, Kolo AM, Jalo HA, Muhammad AS, Mahmud FA, et al. Are fear of COVID-19 and vaccine hesitancy associated with COVID-19 vaccine uptake? A population-based online survey in Nigeria. Vaccines. 2022;10:1271. doi:10.3390/vaccines10081271.
  • Wu N, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, Yip D, Bacon SL. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11:439–52. doi:10.1016/s2213-2600(23)00015-2.
  • Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–60. doi:10.1016/j.ijid.2021.11.009.
  • Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10:132. doi:10.1186/s40249-021-00915-3.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–15. doi:10.1056/NEJMoa2034577.
  • Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21:626–36. doi:10.1038/s41577-021-00592-1.
  • Dhamanti I, Suwantika AA, Adlia A, Yamani LN, Yakub F. Adverse reactions of COVID-19 vaccines: a scoping review of observational studies. Int J Gen Med. 2023;16:609–18. doi:10.2147/ijgm.S400458.
  • Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Razizadeh MH, Turner DL, Turner RJ. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9:467. doi:10.3390/vaccines9050467.
  • Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, Pletcher MJ, Marcus GM. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4:e2140364. doi:10.1001/jamanetworkopen.2021.40364.
  • Kouhpayeh H, Ansari H. Adverse events following COVID-19 vaccination: a systematic review and meta-analysis. Int Immunopharmacol. 2022;109:108906. doi:10.1016/j.intimp.2022.108906.
  • Majumder MAA, Singh K, Johnson WMS, Rajasundaram A, Gupta S, Gaur U, Kumar S, Chatterjee M, Fazle Rabbi AM, Sangishetti VP, et al. Evaluation of short-term side effects following the first dose of COVID-19 vaccines among physicians and dentists: a cross-sectional study from India. J Multidiscip Healthc. 2023;16:161–74. doi:10.2147/jmdh.S390364.
  • Krause PR, Gruber MF. Emergency use authorization of Covid vaccines - safety and efficacy follow-up considerations. N Engl J Med. 2020;383:e107. doi:10.1056/NEJMp2031373.
  • Santi Laurini G, Montanaro N, Broccoli M, Bonaldo G, Motola D. Real-life safety profile of mRNA vaccines for COVID-19: an analysis of VAERS database. Vaccine. 2023;41:2879–86. doi:10.1016/j.vaccine.2023.03.054.
  • Xu K, Wang Z, Qin M, Gao Y, Luo N, Xie W, Zou Y, Wang J, Ma X. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Front Immunol. 2023;14:1113156. doi:10.3389/fimmu.2023.1113156.
  • Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD, et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–23. doi:10.1056/NEJMoa2101765.
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16. doi:10.1056/NEJMoa2035389.
  • Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. Jama. 2021;326:35–45. doi:10.1001/jama.2021.8565.
  • Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J. 2022;98:389–94. doi:10.1136/postgradmedj-2021-140654.
  • Ripabelli G, Sammarco ML, D’Amico A, De Dona R, Iafigliola M, Parente A, Samprati N, Santagata A, Adesso C, Natale A, et al. Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: results from an active pharmacovigilance study in central Italy. Hum Vaccin Immunother. 2022;18:2126668. doi:10.1080/21645515.2022.2126668.
  • Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, Nair N, Martin S, Clark T, Markowitz L, et al. First Month of COVID-19 vaccine safety monitoring — United States, December 14, 2020–January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:283–8. doi:10.15585/mmwr.mm7008e3.
  • Woo EJ, Gee J, Marquez P, Baggs J, Abara WE, McNeil MM, Dimova RB, Su JR. Post-authorization safety surveillance of Ad.26.COV2.S vaccine: reports to the vaccine adverse Event reporting System and v-safe, February 2021–February 2022. Vaccine. 2023;41:4422–30. doi:10.1016/j.vaccine.2023.06.023.
  • Bürzle O, Menges D, Maier JD, Schams D, Puhan MA, Fehr J, Ballouz T, Frei A. Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: population-based cohort. NPJ Vaccines. 2023;8:61. doi:10.1038/s41541-023-00657-3.
  • Torp Hansen K, Kusk Povlsen F, Hammer Bech B, Nygaard Hansen S, Ulrikka Rask C, Fink P, Jørgensen T, Nielsen H, Meinertz Dantoft T, Marie Thysen S, et al. Immediate adverse reactions following COVID-19 vaccination among 16–65-year-old Danish citizens. Vaccine. 2023;41:4879–87. doi:10.1016/j.vaccine.2023.06.069.
  • Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-reported adverse events of COVID-19 vaccines in polish healthcare workers and medical students. Cross-sectional study and pooled analysis of CoVaST project results in central Europe. J Clin Med. 2021;10:5338. doi:10.3390/jcm10225338.
  • Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, Salmon D, Yu H. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021;19:173. doi:10.1186/s12916-021-02059-5.
  • Khouri C, Larabi A, Verger P, Gauna F, Cracowski JL, Ward J. Impact of vaccine hesitancy on onset, severity and type of self-reported adverse events: a French cross-sectional survey. Drug Saf. 2022;45:1049–56. doi:10.1007/s40264-022-01220-0.
  • van Prooijen J-W. An existential threat Model of conspiracy theories. Eur Psychol. 2019;25:16–25. doi:10.1027/1016-9040/a000381.
  • Julian S. Good reasons to vaccinate: mandatory or payment for risk? J Med Ethics. 2021;47:78. doi:10.1136/medethics-2020-106821.
  • Giubilini A, Vaccination SJ. Risks, and freedom: the seat belt analogy. Public Health Ethics. 2019;12:237–49. doi:10.1093/phe/phz014.
  • Saunders B. How mandatory can we make vaccination? Public Health Ethics. 2022;15:220–32. doi:10.1093/phe/phac026.
  • World Health Organization. COVID-19 and mandatory vaccination: ethical considerations. [accessed 2023 Oct 2]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Policy-brief-Mandatory-vaccination-2022.1.
  • Alderotti G, Corvo MF, Buscemi P, Stacchini L, Giorgetti D, Lorini C, Bonaccorsi G, Pinilla MJC, Lastrucci V. Communicating with patients about COVID-19 vaccination: a qualitative study on vaccinators in Tuscany Region, Italy. Vaccines. 2023;11:223. doi:10.3390/vaccines11020223.
  • Hong S-A. COVID-19 vaccine communication and advocacy strategy: a social marketing campaign for increasing COVID-19 vaccine uptake in South Korea. Humanit Soc Sci Commun. 2023;10:109. doi:10.1057/s41599-023-01593-2.
  • Motta M, Sylvester S, Callaghan T, Lunz-Trujillo K. Encouraging COVID-19 vaccine uptake through effective health communication. Front Polit Sci. 2021;3:630133. doi:10.3389/fpos.2021.630133.
  • Al-Rawi A, Fakida A, Grounds K. Investigation of COVID-19 misinformation in Arabic on Twitter: content analysis. JMIR Infodemiol. 2022;2:e37007. doi:10.2196/37007.
  • Sauerland J. Covid-19, Conspiracy narratives, and the Arab State. In: Butter M, Knight P, editors. Covid conspiracy theories in global perspective. London: Routledge; 2023. p. 15.
  • Sallam M, Dababseh D, Yaseen A, Al-Haidar A, Ababneh NA, Bakri FG, Mahafzah A. Conspiracy beliefs are associated with lower Knowledge and higher anxiety levels regarding COVID-19 among students at the university of Jordan. Int J Environ Res Public Health. 2020;17:4915. doi:10.3390/ijerph17144915.
  • Alasmari A, Addawood A, Nouh M, Rayes W, Al-Wabil A. A retrospective analysis of the COVID-19 infodemic in Saudi Arabia. Future Internet. 2021;13:254. doi:10.3390/fi13100254.
  • Paul KT, Eberl JM, Partheymüller J. Policy-relevant attitudes toward COVID-19 vaccination: associations with demography, health risk, and social and political factors. Front Public Health. 2021;9:671896. doi:10.3389/fpubh.2021.671896.
  • Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, Keshavjee S, Graham JE, Baral S. The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health. 2022;7:e008684. doi:10.1136/bmjgh-2022-008684.
  • The Saudi Ministry of Education. The Ministry of education urges all its employees and intermediate and secondary school students to get two doses of the COVID-19 vaccine. [accessed 2023 Jul 3]. https://www.moe.gov.sa/en/mediacenter/MOEnews/Pages/s-2021-274.aspx.
  • Alammari D, Al-Kadri H, Al-Qurashi M, Alshamrani M, Farahat F, Altamimi A, Najjar A. Lessons learned from an academic institution for improving COVID-19 vaccine uptake in Saudi Arabia. East Mediterr Health J. 2023;29:580–6. doi:10.26719/emhj.23.034.
  • The Saudi Ministry of Education. Higher Education. [accessed 2023 Jul 3]. https://icee.sa/about-the-ministry/ministry-of-education/index.html.
  • Alammari D, Al-Kadri H, Al-Qurashi M, Alshamrani M, Farahat F, Altamimi A. Sample size to estimate a proportion or apparent prevalence with specified precision. [accessed 2023 Jul 3]. https://epitools.ausvet.com.au/oneproportion.
  • Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Res. 2016;2:167–72. doi:10.1016/j.pvr.2016.09.001.
  • Caceres MMF, Sosa JP, Lawrence JA, Sestacovschi C, Tidd-Johnson A, Rasool MHU, Gadamidi VK, Ozair S, Pandav K, Cuevas-Lou C, et al. The impact of misinformation on the COVID-19 pandemic. AIMS Public Health. 2022;9:262–77. doi:10.3934/publichealth.2022018.
  • The Saudi Ministry of Health. Saudi Arabia Lifts COVID-19 Precautionary Measures. [accessed 2023 Oct 3]. https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2022-06-16-001.aspx.
  • Yıldırım DF, Serçekuş P, Özkan S. Reasons for individuals’ COVID-19 vaccine hesitations and changing decisions over time: a longitudinal qualitative study. Vacunas. 2022;23:S1–s7. doi:10.1016/j.vacun.2022.06.006.
  • Alhossan A, Alsaran AK, Almahmudi AH, Aljohani ZS, Albishi MR, Almutairi AK. Adverse events of COVID-19 vaccination among the Saudi population: a systematic review and meta-analysis. Vaccines. 2022;10:2089. doi:10.3390/vaccines10122089.
  • Ahlam A, Alnada I, Rhagda A, Mercy J, Ghaida A, Aljohara A. A cross-sectional survey of side effects after COVID-19 vaccination in Saudi Arabia: male versus female outcomes ‎. J Adv Pharm Educ Res. 2021;11:51–6. doi:10.51847/bCwca2qGfP.
  • Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38. doi:10.1038/nri.2016.90.
  • Xiong X, Yuan J, Li M, Jiang B, Lu ZK. Age and gender disparities in adverse events following COVID-19 vaccination: real-world evidence based on big data for risk management. Front Med. 2021;8:700014. doi:10.3389/fmed.2021.700014.
  • Al-Qazaz HK, Al-Obaidy LM, Attash HM. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study. Pharm Pract (Granada). 2022;20:2678. doi:10.18549/PharmPract.2022.2.2678.
  • Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. Vaccines. 2022;10:233. doi:10.3390/vaccines10020233.
  • Di Resta C, Ferrari D, Viganò M, Moro M, Sabetta E, Minerva M, Ambrosio A, Locatelli M, Tomaiuolo R. The gender impact assessment among healthcare workers in the SARS-CoV-2 vaccination—an analysis of serological response and side effects. Vaccines. 2021;9:522. doi:10.3390/vaccines9050522.
  • Izumo T, Kuse N, Awano N, Tone M, Sakamoto K, Takada K, Muto Y, Fujimoto K, Saiki A, Ito Y, et al. Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan. Respir Investig. 2021;59:635–42. doi:10.1016/j.resinv.2021.06.003.
  • Derhovanessian E, Pawelec G. Vaccination in the elderly. Microb Biotechnol. 2012;5:226–32. doi:10.1111/j.1751-7915.2011.00283.x.
  • Kwok KO, Li KK, Tang A, Tsoi MTF, Chan EYY, Tang JWT, Wong A, Wei WI, Wong SYS. Psychobehavioral responses and likelihood of receiving COVID-19 vaccines during the pandemic, Hong Kong. Emerg Infect Dis. 2021;27:1802–10. doi:10.3201/eid2707.210054.
  • Sallam M, Ghazy RM, Al-Salahat K, Al-Mahzoum K, AlHadidi NM, Eid H, Kareem N, Al-Ajlouni E, Batarseh R, Ababneh NA, et al. The role of psychological factors and vaccine conspiracy beliefs in influenza vaccine hesitancy and uptake among Jordanian healthcare workers during the COVID-19 pandemic. Vaccines. 2022;10:1355. doi:10.3390/vaccines10081355.
  • Aljamili AA. Knowledge and practice toward seasonal influenza vaccine and its barriers at the community level in Riyadh, Saudi Arabia. J Family Med Prim Care. 2020;9:1331–9. doi:10.4103/jfmpc.jfmpc_1011_19.
  • Sales IA, Syed W, Almutairi MF, Al Ruthia Y. Public knowledge, attitudes, and practices toward seasonal influenza vaccine in Saudi Arabia: a cross-sectional study. Int J Environ Res Public Health. 2021;18:479. doi:10.3390/ijerph18020479.
  • Alshahrani SM, Zahrani Y. Prevalence and predictors of seasonal influenza vaccine uptake in Saudi Arabia post COVID-19: a web-based online cross-sectional study. Vaccines (Basel). 2023;11:353. doi:10.3390/vaccines11020353.
  • Mahameed H, Al-Mahzoum K, AlRaie LA, Aburumman R, Al-Naimat H, Alhiary S, Barakat M, Al-Tammemi AB, Salim NA, Sallam M, et al. Previous vaccination history and psychological factors as significant predictors of willingness to receive mpox vaccination and a favorable attitude towards compulsory vaccination. Vaccines. 2023;11:897. doi:10.3390/vaccines11050897.
  • Meo SA, Al-Khlaiwi T, Aljofan ZF, Alanazi AI, Meo AS. Public perceptions of the emerging Human monkeypox disease and vaccination in Riyadh, Saudi Arabia: a cross-sectional study. Vaccines (Basel). 2022;10:1534. doi:10.3390/vaccines10091534.
  • Alshahrani NZ, Alzahrani F, Alarifi AM, Algethami MR, Alhumam MN, Ayied HAM, Awan AZ, Almutairi AF, Bamakhrama SA, Almushari BS, et al. Assessment of Knowledge of monkeypox Viral infection among the general population in Saudi Arabia. Pathogens. 2022;11:904. doi:10.3390/pathogens11080904.
  • Marco-Franco JE, Pita-Barros P, Vivas-Orts D, González-de-Julián S, Vivas-Consuelo D. COVID-19, fake news, and vaccines: should regulation be implemented? Int J Environ Res Public Health. 2021;18(2):744. doi:10.3390/ijerph18020744.
  • Colautti L, Cancer A, Magenes S, Antonietti A, Iannello P. Risk-perception change associated with COVID-19 vaccine’s side effects: the role of individual differences. Int J Environ Res Public Health. 2022;19(3):1189. doi:10.3390/ijerph19031189.
  • Malthouse E. Confirmation bias and vaccine-related beliefs in the time of COVID-19. J Public Health (Oxf). 2023;45:523–8. doi:10.1093/pubmed/fdac128.
  • Acar K, Horntvedt O, Cabrera A, Olsson A, Ingvar M, Lebedev AV, Petrovic P. COVID-19 conspiracy ideation is associated with the delusion proneness trait and resistance to update of beliefs. Sci Rep. 2022;12:10352. doi:10.1038/s41598-022-14071-7.
  • Hause AM, Gee J, Johnson T, Jazwa A, Marquez P, Miller E, Su J, Shimabukuro TT, Shay DK. Anxiety-related adverse event clusters after Janssen COVID-19 vaccination — five U.S. Mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:685–8. doi:10.15585/mmwr.mm7018e3.
  • Šrol J, Ballová Mikušková E, Čavojová V. When we are worried, what are we thinking? Anxiety, lack of control, and conspiracy beliefs amidst the COVID-19 pandemic. Appl Cogn Psychol. 2021;35:720–9. doi:10.1002/acp.3798.
  • Kevin B, Alex de F, Rachel G-A, Euzebiusz J, James D, Trudo L, Keshavjee S, Graham JE, Baral S. The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health. 2022;7:e008684. doi:10.1136/bmjgh-2022-008684.
  • Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, et al. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. Lancet. 2022;400:535–8. doi:10.1016/s0140-6736(22)00875-3.
  • Olick RS, Shaw J, Yang YT. Ethical issues in mandating COVID-19 vaccination for health care personnel. Mayo Clin Proc. 2021;96:2958–62. doi:10.1016/j.mayocp.2021.10.020.
  • Horton R. Offline: complacency threatens progress against COVID-19. Lancet. 2022;399:615. doi:10.1016/S0140-6736(22)00266-5.
  • Van Oost P, Yzerbyt V, Schmitz M, Vansteenkiste M, Luminet O, Morbée S, Van den Bergh O, Waterschoot J, Klein O. The relation between conspiracism, government trust, and COVID-19 vaccination intentions: the key role of motivation. Social Sci Med. 2022;301:114926. doi:10.1016/j.socscimed.2022.114926.
  • Lewandowsky S, Holford D, Schmid P. Public policy and conspiracies: the case of mandates. Curr Opin Psychol. 2022;47:101427. doi:10.1016/j.copsyc.2022.101427.
  • de Koning R, Egiz A, Kotecha J, Ciuculete AC, Ooi SZY, Bankole NDA, de Koning R, Erhabor J, Higginbotham G, Khan M, et al. Survey fatigue during the COVID-19 pandemic: an analysis of neurosurgery survey response rates. Front Surg. 2021;8:690680. doi:10.3389/fsurg.2021.690680.
  • Jeong D, Aggarwal S, Robinson J, Kumar N, Spearot A, Park DS. Exhaustive or exhausting? Evidence on respondent fatigue in long surveys. J Dev Econ. 2023;161:102992. doi:10.1016/j.jdeveco.2022.102992.